Skip to main content
. 2020 Nov 17;13:100267. doi: 10.1016/j.ynstr.2020.100267

Fig. 4.

Fig. 4

U50,488 suppressed glutamatergic transmission onto LHb neurons. A. Top: representative AMPAR-mediated mEPSC traces recorded from LHb neurons before (baseline, black) and after U50,488 (10 μM, red) application. U50,488 had a trending decrease in the mean amplitude of mEPSCs but significantly decreased cumulative probability of mEPSC amplitude. B. U50,488 treatment decreased the average mEPSC frequency and cumulative probability of inter-event intervals of mEPSCs. #p = 0.066, **p < 0.01, ***p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)